Ayman Elnail

• CITI Program: Biomedical Researchers-Human Subject Research March 2025
• ECFMG certified:

- USMLE Step 1 : 259, 1st attempt, 2021

- USMLE Step 2 : 253, 1st attempt, 2022

- USMLE Step 3 : 242, 1st attempt, 2026

1- Elnail A,Gasim R,Choi E, Rosales S, Sulaj D, MacDonald M. Improving Medication Reconciliation Completion Rates on Internal Medicine Wards: A Quality Improvement Initiative. Quality Improvement Poster Presentation, Englewood Health, Department of Medicine, 2026.

2- Mohamed E, Modi L, Elnail A, Adam E, Foster A, Klein W. Tirzepatide-Associated Ischemic Colitis: An Emerging Adverse Effect. Poster presented and abstract published in ACG Annual Scientific Meeting.

3- Choi E, Elnail A, Qie V, Barnes T. Massive Gastrointestinal Hemorrhage as an Initial Presentation of Invasive Pancreatic Cancer. Poster presented and abstract published in ACG Annual Scientific Meeting. 2025.

4- Elnail A, Eliava S, Khraisat O, Choi E, Ahmed M, Patel D. Atypical Echo: Unexpected Recurrence of Carcinoid Tumor in a Novel Location. Poster presented and abstract published in ACG Annual Scientific Meeting. 2025.

5- Eliava S, Mohamed E, Elnail A, Choi E, Gudushauri N, Tskhakaia I. Impact of Obesity on Mortality and Clinical Outcomes in Patients With Alcoholic Hepatitis: A Retrospective Matched Cohort Analysis.